Sartorius | SRT3 - Ordinary Share Capital


Sartorius reported EUR69.05M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 260.32M 333K Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
Sartorius EUR 69.05M 0 Mar/2026
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025